Yutaka Shima

718 total citations
15 papers, 391 citations indexed

About

Yutaka Shima is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Yutaka Shima has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Yutaka Shima's work include Acute Myeloid Leukemia Research (7 papers), Protein Degradation and Inhibitors (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Yutaka Shima is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Protein Degradation and Inhibitors (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Yutaka Shima collaborates with scholars based in Japan, United Kingdom and United States. Yutaka Shima's co-authors include Issay Kitabayashi, Kazuo Umezawa, Tatsuro Irimura, Tomoki Chiba, Pier Paolo Pandolfi, Masaru Murai, Jun Nakashima, Yutaka Horiguchi, Mototsugu Oya and Takashi Ohigashi and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Yutaka Shima

14 papers receiving 385 citations

Peers

Countries citing papers authored by Yutaka Shima

Since Specialization

Citations

This map shows the geographic impact of Yutaka Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Shima more than expected).

Fields of papers citing papers by Yutaka Shima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Shima. The network helps show where Yutaka Shima may publish in the future.

Co-authorship network of co-authors of Yutaka Shima

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Shima. A scholar is included among the top collaborators of Yutaka Shima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Shima. Yutaka Shima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	CTCF Is Essential for the Development and Maintenance of CALM ‐ AF10 ‐Induced Leukemia 2025 ·Cancer Science ·Yoko Kuroki, Kazutsune Yamagata, Yukiko Aikawa, Yutaka Shima, (unknown), Issay Kitabayashi	0
2	Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1 2022 ·International Journal of Hematology ·(unknown), Kazutsune Yamagata, Haruka Shinohara, Yutaka Shima, Takuo Katsumoto, Yukiko Aikawa, Issay Kitabayashi	8
3	CDKN1C‐mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib 2021 ·Cancer Science ·Yuki Kagiyama, (unknown), Yutaka Shima, Kazutsune Yamagata, Takuo Katsumoto, Makoto Nakagawa, Daisuke Honma, Nobuaki Adachi, Kazushi Araki, Ayako Kato, Koichiro Inaki, (unknown), Suguru Fukuhara, Yukio Kobayashi, Kensei Tobinai, Issay Kitabayashi	17
4	An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia 2020 ·Nature Cancer ·Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, (unknown), Kyle Spinler, Eric L. Van Nostrand, Brian A. Yee, Steven M. Blue, (unknown), (unknown), Charles Chuah, Vivian G. Oehler, H. Elizabeth Broome, Roman Šášik, James Scott‐Browne, Anjana Rao, G Yeo, Tannishtha Reya	37
5	IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia 2015 ·Cancer Research ·Yoko Ogawara, Takuo Katsumoto, Yukiko Aikawa, Yutaka Shima, Yuki Kagiyama, Tomoyoshi Soga, Hironori Matsunaga, Takahiko Seki, Kazushi Araki, Issay Kitabayashi	45
6	Gene Expression Profiles of the Cochlea and Vestibular Endorgans 2015 ·Annals of Otology Rhinology & Laryngology ·Shin‐ya Nishio, Mitsuru Hattori, Hideaki Moteki, Keita Tsukada, Maiko Miyagawa, (unknown), Hidekane Yoshimura, Yoh-ichiro Iwasa, Kentaro Mori, Yutaka Shima, Naoko Sakuma, Shin‐ichi Usami	34
7	Essential role of PU.1 in maintenance of mixed lineage leukemia‐associated leukemic stem cells 2014 ·Cancer Science ·Yukiko Aikawa, Kazutsune Yamagata, Takuo Katsumoto, Yutaka Shima, (unknown), E. Richard Stanley, Michael L. Cleary, Koichi Akashi, Daniel G. Tenen, Issay Kitabayashi	13
8	PML-RARα and Its Phosphorylation Regulate PML Oligomerization and HIPK2 Stability 2013 ·Cancer Research ·Yutaka Shima, (unknown), Issay Kitabayashi	14
9	Critical Roles Of The IDH2 Mutation In Development and Maintenance Of Acute Myeloid Leukemia 2013 ·Blood ·Yoko Ogawara, Takuo Katsumoto, Yukiko Aikawa, Yutaka Shima, Yuki Kagiyama, Hironori Matsunaga, Takahiko Seki, Issay Kitabayashi	1
10	Deregulated transcription factors in leukemia 2011 ·International Journal of Hematology ·Yutaka Shima, Issay Kitabayashi	26
11	PML Activates Transcription by Protecting HIPK2 and p300 from SCF^Fbx3-Mediated Degradation 2008 ·Molecular and Cellular Biology ·Yutaka Shima, (unknown), Tomoki Chiba, Tatsuro Irimura, Pier Paolo Pandolfi, Issay Kitabayashi	68
12	Inhibition of Cellular Adhesion in Human Umbilical Vein Endothelial Cells by NF-κB Inhibitor DHMEQ Under Flow 2005 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Osamu Ohno, Yutaka Shima, Yasuo Ikeda, Kumi Sakurai, Kiyoaki Watanabe, Yohko Kawai, Kazuo Umezawa	6
13	Molecular design, chemical synthesis and biological evaluation of quinoxaline–carbohydrate hybrids as novel and selective photo-induced DNA cleaving and cytotoxic agents 2003 ·Tetrahedron ·Kazunobu Toshima, Tomonori Kimura, (unknown), Tomohiro Ozawa, (unknown), Yutaka Shima, Kazuo Umezawa, Shuichi Matsumura	17
14	Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. 2003 ·PubMed ·(unknown), Yutaka Horiguchi, Jun Nakashima, Kenji Kuroda, Mototsugu Oya, Takashi Ohigashi, Nozomu Takahashi, Yutaka Shima, Kazuo Umezawa, Masaru Murai	100
15	Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells 2001 ·International Journal of Oncology ·Osamu Ohno, Yutaka Shima, Yoko Ikeda, (unknown), Kuniki Kato, Masakazu Toi, Kazuo Umezawa	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact